abstract |
The invention provides novel β2-adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2-adrenergic receptor activity, and processes and intermediates useful for preparing such compounds. |